Next Day Disclosure Return
Filed with HKEX · Stock code 2630 · · 5 pages · English
Vigonvita Life Sciences Co., Ltd. on 6ix
Earlier from Vigonvita Life Sciences
- Voluntary announcement - (1) the new drug application (NDA) for semenafil hydrochloride tablets has been accepted by the department of health of hong kong, China and the pharmaceutical administration bureau of macao, China; and (2) clarification announcement in relation to the interim report for the six months ended June 30, 2026
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
Follow Vigonvita Life Sciences into a list and get an email when it puts out news.
Follow Vigonvita Life Sciences